Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $8,073 | 565 | 99.8% |
| Education | $16.98 | 2 | 0.2% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $1,461 | 106 | $0 (2024) |
| Amgen Inc. | $866.65 | 49 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $705.32 | 47 | $0 (2024) |
| PFIZER INC. | $620.93 | 47 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $508.92 | 27 | $0 (2024) |
| GlaxoSmithKline, LLC. | $436.70 | 33 | $0 (2024) |
| Lilly USA, LLC | $416.56 | 32 | $0 (2024) |
| Merck Sharp & Dohme LLC | $396.44 | 42 | $0 (2024) |
| ABBVIE INC. | $388.04 | 27 | $0 (2024) |
| SANOFI-AVENTIS U.S. LLC | $251.18 | 17 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,508 | 86 | Novo Nordisk Inc ($280.79) |
| 2023 | $1,094 | 64 | Novo Nordisk Inc ($171.52) |
| 2022 | $574.45 | 34 | Novo Nordisk Inc ($176.12) |
| 2021 | $810.66 | 55 | Novo Nordisk Inc ($160.86) |
| 2020 | $786.83 | 56 | GlaxoSmithKline, LLC. ($114.21) |
| 2019 | $1,316 | 117 | Novo Nordisk Inc ($173.46) |
| 2018 | $1,050 | 82 | Amgen Inc. ($226.09) |
| 2017 | $950.65 | 73 | Novo Nordisk Inc ($235.74) |
All Payment Transactions
567 individual payment records from CMS Open Payments — Page 1 of 23
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/04/2024 | Xeris Pharmaceuticals, Inc. | GVOKE HYPOPEN (Drug) | Food and Beverage | In-kind items and services | $19.70 | General |
| Category: Diabetes | ||||||
| 12/03/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $4.25 | General |
| Category: Diabetes | ||||||
| 12/02/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $20.94 | General |
| Category: Diabetes Care | ||||||
| 11/25/2024 | Novo Nordisk Inc | Rybelsus (Drug), Ozempic | Food and Beverage | In-kind items and services | $28.75 | General |
| Category: Diabetes | ||||||
| 11/21/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $12.52 | General |
| Category: PAIN | ||||||
| 11/19/2024 | Seqirus USA Inc | Fluad (Biological), Flucelvax | Food and Beverage | In-kind items and services | $16.92 | General |
| Category: Vaccines | ||||||
| 11/18/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $22.43 | General |
| Category: NEUROSCIENCE | ||||||
| 11/14/2024 | ABBVIE INC. | UBRELVY (Drug) | Food and Beverage | In-kind items and services | $18.04 | General |
| Category: NEUROSCIENCE | ||||||
| 11/12/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $24.91 | General |
| Category: Diabetes | ||||||
| 11/04/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $20.63 | General |
| Category: VACCINES | ||||||
| 10/31/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $7.43 | General |
| Category: Diabetes | ||||||
| 10/29/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $18.38 | General |
| Category: DIABETES | ||||||
| 10/24/2024 | ABBVIE INC. | QULIPTA (Drug), UBRELVY | Food and Beverage | In-kind items and services | $12.09 | General |
| Category: NEUROSCIENCE | ||||||
| 10/22/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $28.54 | General |
| Category: Diabetes | ||||||
| 10/11/2024 | Exact Sciences Corporation | Cologuard Collection Kit (Device) | Food and Beverage | In-kind items and services | $14.58 | General |
| Category: Oncology | ||||||
| 10/09/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $18.01 | General |
| Category: PAIN | ||||||
| 10/07/2024 | AstraZeneca Pharmaceuticals LP | FARXIGA (Drug) | Food and Beverage | In-kind items and services | $15.90 | General |
| Category: Cardiovascular and Metabolism | ||||||
| 10/03/2024 | Abbott Laboratories | FREESTYLE LIBRE 3 (Device) | Food and Beverage | In-kind items and services | $16.00 | General |
| Category: Diabetes Care | ||||||
| 10/01/2024 | Phathom Pharmaceuticals, Inc. | VOQUEZNA (Drug) | Food and Beverage | In-kind items and services | $16.27 | General |
| Category: GASTROENTEROLOGY | ||||||
| 09/30/2024 | Lilly USA, LLC | MOUNJARO (Drug), ZEPBOUND | Food and Beverage | In-kind items and services | $10.14 | General |
| Category: Diabetes | ||||||
| 09/24/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $18.41 | General |
| Category: Hepatitis B Vaccine | ||||||
| 09/17/2024 | Amgen Inc. | Otezla (Drug), Repatha | Food and Beverage | In-kind items and services | $13.41 | General |
| Category: Inflammation | ||||||
| 09/11/2024 | SANOFI-AVENTIS U.S. LLC | TZIELD (Biological) | Food and Beverage | In-kind items and services | $24.27 | General |
| Category: Endocrine & Metabolic Diseases | ||||||
| 09/10/2024 | Boehringer Ingelheim Pharmaceuticals, Inc. | JARDIANCE (Drug) | Food and Beverage | In-kind items and services | $20.67 | General |
| Category: DIABETES | ||||||
| 09/04/2024 | Novo Nordisk Inc | — | Food and Beverage | In-kind items and services | $14.95 | General |
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 35 | 1,908 | 3,259 | $207,470 | $79,616 |
| 2022 | 30 | 1,848 | 3,031 | $184,582 | $70,626 |
| 2021 | 33 | 1,596 | 2,692 | $157,406 | $64,818 |
| 2020 | 26 | 1,326 | 2,307 | $130,392 | $49,050 |
All Medicare Procedures & Services
124 procedure records from CMS Medicare Utilization — Page 1 of 5
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 133 | 331 | $76,130 | $25,195 | 33.1% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 94 | 94 | $31,020 | $11,211 | 36.1% |
| 90662 | Influenza vaccine split virus, preservative free | Office | 2023 | 68 | 68 | $5,780 | $4,819 | 83.4% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 50 | 70 | $11,060 | $3,832 | 34.6% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 130 | 291 | $9,312 | $3,792 | 40.7% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 135 | 412 | $5,648 | $3,378 | 59.8% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 133 | 316 | $6,636 | $3,250 | 49.0% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 105 | 188 | $7,520 | $3,078 | 40.9% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 99 | 237 | $5,451 | $2,237 | 41.0% |
| G0472 | Hepatitis c antibody screening, for individual at high risk and other covered indication(s) | Office | 2023 | 49 | 49 | $3,920 | $2,226 | 56.8% |
| 91322 | Sarscov2 vac 50 mcg/0.5ml im | Office | 2023 | 15 | 15 | $6,285 | $2,145 | 34.1% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 76 | 76 | $3,572 | $2,133 | 59.7% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 111 | 232 | $4,408 | $1,758 | 39.9% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 93 | 93 | $4,650 | $1,566 | 33.7% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 52 | 110 | $2,310 | $963.56 | 41.7% |
| 93306 | Ultrasound of heart with color-depicted blood flow, rate, direction and valve function | Office | 2023 | 12 | 12 | $4,296 | $936.75 | 21.8% |
| 82306 | Vitamin d-3 level | Office | 2023 | 22 | 22 | $1,518 | $638.22 | 42.0% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 92 | 103 | $3,296 | $582.98 | 17.7% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 36 | 40 | $1,440 | $576.42 | 40.0% |
| 90480 | Admn sarscov2 vacc 1 dose | Office | 2023 | 15 | 15 | $1,725 | $568.95 | 33.0% |
| 83735 | Magnesium level | Office | 2023 | 52 | 82 | $1,312 | $538.74 | 41.1% |
| 82570 | Creatinine level to test for kidney function or muscle injury | Office | 2023 | 93 | 104 | $1,352 | $528.32 | 39.1% |
| 87811 | Detection test by immunoassay with direct visual observation for severe acute respiratory syndrome coronavirus 2 (covid-19) | Office | 2023 | 13 | 13 | $936.00 | $527.15 | 56.3% |
| 87804 | Detection test by immunoassay with direct visual observation for influenza virus | Office | 2023 | 14 | 28 | $756.00 | $454.16 | 60.1% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 27 | 33 | $1,056 | $427.52 | 40.5% |
About Dr. Kathy Chism, MD
Dr. Kathy Chism, MD is a Family Medicine healthcare provider based in Powell, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 06/10/2006. The National Provider Identifier (NPI) number assigned to this provider is 1710929484.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Kathy Chism, MD has received a total of $8,090 in payments from pharmaceutical and medical device companies, with $1,508 received in 2024. These payments were reported across 567 transactions from 48 companies. The most common payment nature is "Food and Beverage" ($8,073).
As a Medicare-enrolled provider, Chism has provided services to 6,678 Medicare beneficiaries, totaling 11,289 services with total Medicare billing of $264,110. Data is available for 4 years (2020–2023), covering 124 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Powell, TN
- Active Since 06/10/2006
- Last Updated 04/30/2008
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1710929484
Products in Payments
- JARDIANCE (Drug) $626.45
- Ozempic (Drug) $501.59
- FARXIGA (Drug) $287.34
- JANUVIA (Drug) $278.33
- Otezla (Drug) $265.52
- Victoza (Drug) $248.97
- Rybelsus (Drug) $228.28
- Repatha (Biological) $224.70
- Saxenda (Drug) $219.71
- VRAYLAR (Drug) $216.78
- Prolia (Biological) $198.66
- UBRELVY (Drug) $195.52
- Aimovig (Biological) $177.77
- NURTEC ODT (Drug) $163.44
- CHANTIX (Drug) $159.53
- XARELTO (Drug) $158.03
- ELIQUIS (Drug) $154.95
- SHINGRIX (Biological) $154.88
- BEXSERO (Biological) $154.82
- Kerendia (Drug) $147.23
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Powell
Mark Johnson, Md, MD
Family Medicine — Payments: $14,291
Brad Flaming, Md, MD
Family Medicine — Payments: $8,139
Nicholas Thornton, Md, MD
Family Medicine — Payments: $7,874
Rhea Dean, Md, MD
Family Medicine — Payments: $5,491
Julius Vonclef, Md, MD
Family Medicine — Payments: $4,741
Lee Toney, Md, MD
Family Medicine — Payments: $4,516